- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
JB Chemicals non-executive director Sanjay Nayar steps down
Mumbai: J. B. Chemicals & Pharmaceuticals Ltd. has recently announced that Mr. Sanjay Nayar, non-executive director, has resigned as a director of the company effective January 25, 2022."This is to inform you that Mr. Sanjay Nayar, non-executive director, has resigned as a director of J. B. Chemicals & Pharmaceuticals Ltd. effective January 25, 2022 due to other commitments,"...
Mumbai: J. B. Chemicals & Pharmaceuticals Ltd. has recently announced that Mr. Sanjay Nayar, non-executive director, has resigned as a director of the company effective January 25, 2022.
"This is to inform you that Mr. Sanjay Nayar, non-executive director, has resigned as a director of J. B. Chemicals & Pharmaceuticals Ltd. effective January 25, 2022 due to other commitments," the company said in a BSE filing.
" Sanjay Nayar is Chairman of KKR India. He joined KKR in 2009 and was Partner & CEO of KKR India until January 2021. Prior to joining KKR, he served as CEO of Citigroup's Indian and South Asian operations," reads details of Nayar on JB Chemicals' official site.
He was a member of Citigroup's Management Committee and Asia Executive Operating Committee from 2002 – 2009. Mr. Nayar also served Citibank/Citigroup for 25 years in various positions in India, UK, and USA. Mr. Nayar is a member of the Board of US-India Strategic Partnership Forum (USISPF), the Governing Board of Indian School of Business (ISB), is an Executive Member of CII PE/VC Committee, and as recently as November 2020 tenured from SEBI's NISM Board of Governors after six years. He has obtained a B.Sc. (Hons) from the Delhi College of Engineering and an MBA (Finance) from the Indian Institute of Management, Ahmedabad.
Read also: JB Chemicals to strike Rs 628 crore deal with Sanzyme for probiotic, reproductive brands
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751